|
|
 |
| |
|
|
| |
|
|
| |
|
| Synonyms: |
Vfend, Pfizer brand of voriconazole, UK-109496, UK-109,496, UK 109496, UK 109,496, C102790
|
| Chemical Name: |
(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol |
| Molecular Formula: |
|
| Molecular Weight : |
349.311 |
| CAS No. : |
137234-62-9 |
| Chemical Structure: |
|
| Specification: |
USP/EP |
Pharmacodynamic
Properties: |
Voriconazole Tablets are indicated for use in patients 12 years of age and older in the treatment of the following fungal infections:
Invasive Aspergillosis: In clinical trials, the majority of isolates recovered were Aspergillus fumigatus. There was a small number of cases of culture proven disease due to species of Aspergillus other than A. fumigatus.
Candidemia in Non-neutropenic Patients and the Following Candida Infections: Disseminated Infections in Skin and Infections in Abdomen, Kidney, Bladder Wall, and Wounds.
Esophageal Candidiasis;
Serious Fungal Infections Caused by Scedosporium apiospermum (asexual Form of Pseudallescheria boydii) and Fusarium spp. Including Fusarium solani, in Patients Intolerant of, or Refractory to, Other Therapy.
Specimens for fungal culture and other relevant laboratory studies (including histopathology) should be obtained prior to therapy to isolate and identify causative organism(s). Therapy may be instituted before the results of the cultures and other laboratory studies are known. However, once these results become available, antifungal therapy should be adjusted accordingly.
|
| Storage: |
Keep container tightly closed in a cool, well-ventilated area. |
| MSDS: |
Provide as per request after the order or contract is signed. |
|
|
| |
[Disclaimer]
(1) All rights reserved. Reproduction in whole or part expressly forbidden without written permission.
(2) We make effort to ensure the information presented here is accurate, but does not purport to be all inclusive and shall be used only as a reference.
(3) We make no warranty, express or implied, with respect to such information, and we assume no liability resulting from its use. Users should make their own investigations to determine the suitability of the information for their particular purposes. |
|
 |
|
|
